Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.5 (
neuropathy target esterase
)
1,070
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phospholipase and
lysophospholipase
activities were assayed in goat epididymal
spermatozoa
. Lysophospholipase was 10 times more active than phospholipase, and both enzymes decreased in activity substantially in the transit of
spermatozoa
from the caput to the cauda epididymidis. A comparative study revealed that phosphatidyl-ethanolamine, -choline and -inositol and phosphatidic acid were hydrolysed by goat sperm phospholipase. Hydrolysis of phosphatidylethanolamine/phosphatidylcholine revealed the end products to be glycerophosphoethanolamine/choline but neither diglycerides nor lysophosphatidylethanolamine/lysophosphatidylcholine were detected.
...
PMID:Phospholipase and lysophospholipase activities of goat spermatozoa in transit from the caput to the cauda epididymidis. 404 28
The
lysophospholipase
of human
spermatozoa
was purified to homogeneity by sequential ion-exchange, gel filtration, and hydrophobic chromatography. The final preparation exhibited a single protein band on SDS-PAGE. The molecular mass of the enzyme was estimated to be 51 kDa by SDS-PAGE and 52 kDa by gel filtration. The optimal pH of this enzyme is 8.0. Polyclonal antibodies against
lysophospholipase
were prepared by placing the enzyme adsorbed on nitrocellulose directly into the spleen of rabbits. These antibodies were purified by protein A-agarose and by affigel-
lysophospholipase
chromatography. The purified antibodies and enzyme were used to study the possible role of
lysophospholipase
in the acrosome reaction. The addition of these antibodies led to an increase in the acrosome reaction, thus suggesting that inhibition of
lysophospholipase
produces a higher lysophosphatidylcholine concentration and results in an acrosome reaction level similar to that obtained by the calcium ionophore A23187. Immunofluorescence localization of the enzyme indicated that the enzyme is located on the head of
spermatozoa
. The purified sperm
lysophospholipase
and its specific antibodies represent important tools for the study of the regulation of this enzyme in reproductive processes. Furthermore, the study of this enzyme will allow evaluation of the mechanisms underlying the acrosome reaction.
...
PMID:Purification of lysophospholipase of human spermatozoa and its implication in the acrosome reaction. 775 55
Changes in lipid composition of turkey semen have previously been reported to occur during in vitro storage and may be mediated by endogenous hydrolysis of phospholipids. To investigate the presence of phospholipases able to initiate such degradation, phospholipaseA2 (PLA2), phospholipase A1 (PLA1), and
lysophospholipase
(LPLase) activities were measured in turkey
spermatozoa
and seminal plasma. These enzymes were also measured in the oviductal fluid because they may be involved in the process prior to fertilization in the female. In
spermatozoa
and seminal plasma, the major PLA2 was a calcium-dependent and sodium deoxycholate (DOC) stimulated enzyme. However, calcium-independent PLA2 activities were also detected with different characteristics in
spermatozoa
(DOC inhibited enzyme) and seminal plasma (DOC stimulated enzyme). Additionally, PLA1 activity and high LPLase activity were present in
spermatozoa
and seminal plasma. In vitro storage of semen for 48 h did not affect PLA2 and LPLase activities. By contrast, PLA1 was the major phospholipase activity detected in oviductal fluid. A PLA2 activity stimulated by calcium or DOC and LPLase activity were also detected, but both were low relative to PLA1. These results showed that turkey semen had several enzymatic activities able to hydrolyze phospholipids. In addition, the phospholipase activities described here in the oviductal fluid could be involved in membrane destabilization prior to fertilization.
...
PMID:Activity of phospholipases A and lysophospholipase in turkey semen and oviducal fluid. 1533 15
Phospholipase A(2) controls the phospholipid composition in spermatozoal membranes and is released from the acrosome of human
spermatozoa
. The extracellular phospholipase A(2) activity of human
spermatozoa
was determined by matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry after destabilization of acrosome by the calcium-ionophore calcimycin. MALDI-TOF mass spectrometry allowed the monitoring of changes in both substrate and products of spermatozoal phospholipase A(2) (PLA(2)) without the use of labelled phospholipids. The spermatozoal PLA(2) was characterized as a secretory one (sPLA(2)). Secretory PLA(2) exhibited a high substrate specificity for 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine (PDPC), the most abundant spermatozoal phospholipid. A time- and cell number-dependent formation of the lysophospholipid PDPC was observed following incubation of extracellular medium of calcimycin-treated
spermatozoa
(CTS) with PDPC. Antibodies against sPLA(2), specific inhibitors of sPLA(2) and Ca(2+)-chelators could inhibit its generation. An antibody against
lysophospholipase
enhanced the lysoproduct concentration in the extracellular medium of CTS containing sPLA(2) because further metabolization of these products was blocked. The results demonstrated that destabilization of the acrosome is able to induce a release of secretory phospholipase A(2) from human
spermatozoa
with subsequent generation of lysophosphocholine in the surrounding of
spermatozoa
.
...
PMID:Destabilization of the acrosome results in release of phospholipase A2 from human spermatozoa and subsequent formation of lysophospholipids. 1652 78